Very late erosion of amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement

Roberts, Will T.; Parmar, Jitendra; Rajathurai, Thirumaran

doi:10.1002/ccd.24755

Cited by 24 publications

(13 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Tissue erosion following transcatheter ASD closure, although highly unusual, is typically seen within 72 hours of device placement. Nevertheless, cases of late tissue erosion have been reported in the literature, as remote as 8 years after implantation . The rate of tissue erosion has been estimated to be 0.1–0.3%.…”

Section: Discussionmentioning

confidence: 99%

Late tissue erosion after transcatheter closure of an atrial septal defect

Mendirichaga

Smairat

Sancassani

2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

We present the case of a 27-year-old male presenting with sudden-onset retrosternal chest pain, dyspnea, and cardiac tamponade due to erosion of an Amplatzer Atrial Septal Occluder (ASO) through the left atrial wall 4 years after placement. Emergent surgical management of the hemopericardium, followed by surgical removal of the device, repair of the left atrial wall perforation, and patch closure of the atrial septal defect (ASD) were performed successfully. Tissue erosion leading to hemopericardium and cardiac tamponade should be suspected in subjects with a history of transcatheter ASD closure who present with acute chest pain or dyspnea and signs of hemodynamic instability © 2015 Wiley Periodicals, Inc.

show abstract

Section: Discussionmentioning

confidence: 99%

Late tissue erosion after transcatheter closure of an atrial septal defect

Mendirichaga

Smairat

Sancassani

2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…Device embolisation is the most common complication (prevalence 0.55-0.62%), often requiring surgical retrieval (Levi and Moore, 2004;Moore et al, 2013). Another rare, but potentially fatal complication is erosion or cardiac perforation (reported only with certain device types), estimated to occur in 0.1% to 0.28% of all cases and reported as late as eight years after deployment (Amin et al, 2004;DiBardino et al, 2009;Moore et al, 2013;Roberts et al, 2013). More rarely, device infection with subsequent endocarditis, nickel allergy, thrombus formation or residual/recurrent defect following device closure can occur (DiBardino et al, 2009;Moore et al, 2013).…”

Section: Introductionmentioning

confidence: 99%

Transcatheter Vs. Surgical Closure of Atrial Septal Defects in Adults

Rudzītis

Sablinskis

Lurina

et al. 2018

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.

View full text Add to dashboard Cite

Percutaneous transcatheter device closure of secundum atrial septal defects (ASD) has now largely replaced surgical closure in most centres. The aim of this study was to compare results of transcatheter and surgical ASD closure in adults in Latvia during the years 2002–2014 and to analyse long-term outcomes of transcatheter closure. We analysed data from 334 patients with secundum ASD who underwent ASD closure in Pauls Stradiņš Clinical University Hospital. Patients were included into device or surgical closure groups. In the device group, three follow-ups were made 1, 6, and 12 months after the procedure. No follow-up data were available for surgical arm patients beyond their hospitalisation period. The mean age of patients was 45.3 ± 19.9 years for the device group and 40.0 ± 16.9 years for the surgical group (p = 0.023). The mean secundum ASD size in the device and surgical groups was 14.2 ± 5.6 mm and 28.7 ± 10.0 mm, respectively (p < 0.001). No differences were observed regarding procedure success rates: 99.2% in the device group and 100% in the surgical group (p = 0.451). Periprocedural complications generally were more common in the surgical closure group. The study results show a successful introduction of the percutaneous ASD closure method in Latvia with good early and late outcomes and without significant differences in procedure success rate compared to surgical closure.

show abstract

“…It can occur within 72 hours of implantation 2,3 or even years later requiring surgical treatment or leading to death. 4,5 Early and recurrent development of pericardial effusion has been described among predictors for this complication but is it always the case? 6…”

mentioning

confidence: 99%

Not just another large atrial septal defect: complex anatomy, challenging procedure, and an unusual complication

2020

View full text Add to dashboard Cite

AbstractWe report the case of a 59-year-old patient with a complex atrial septal defect in whom a 40-mm Amplatzer™ septal occluder was surgically extracted 50 days following implantation. Deployment manoeuvres were challenging leading to an immediate pericardial effusion that was closely monitored and uneventfully drained after 11 days. A dry pericardium was documented until 4 weeks of outpatient routine follow-up. However, the device was surgically explanted 2 weeks later, when an urgent chest computed tomography performed for worrisome symptoms showed pericardial effusion recurrence with peripheral contrast enhancement. Surprisingly, the surgical view showed a well-positioned device and an intact pericardium. We discuss the atypical sequence of clinical findings misleading our clinical judgement and precipitating surgery.

show abstract

Very late erosion of amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement

Cited by 24 publications

References 5 publications

Late tissue erosion after transcatheter closure of an atrial septal defect

Late tissue erosion after transcatheter closure of an atrial septal defect

Transcatheter Vs. Surgical Closure of Atrial Septal Defects in Adults

Not just another large atrial septal defect: complex anatomy, challenging procedure, and an unusual complication

Contact Info

Product

Resources

About